Details of the Drug

General Information of Drug (ID: DM382VP)

• Drug Name: Recombinant botulinum toxin vaccine
• Synonyms: RBOT; Recombinant botulinum toxin vaccine (intramuscular formulation); Recombinant botulinum toxin vaccine, Emergent BioSolutions; Botulinum toxin vaccine (recombinant), Emergent BioSolutions; Botulinum toxin vaccine (recombinant), Emergent BioSolutions/Health Protection Agency; Recombinant botulinum toxin vaccine (intramuscular formulation), Emergent BioSolutions/Health Protection Agency

Indication

Disease Entry	ICD 11	Status	REF
Yersinia infection	1B93	Phase 2	[1]

• Cross-matching ID: TTD ID: D01IZE

References

• [1] CSC's dynport vaccine company releases results for Phase 2 botulinum vaccine clinical trial. CSC. January 24, 2012.